Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. National Institute of Health, National Institue on Drug Abuse. Hospitalization of patients with cocaine and amphetamine use disorders from a psychiatric emergency service. Leamon MH, Gibson DR, Canning RD, Benjamin L. Baltimore, Md: Lippincott Williams & Wilkins 1993. Pocket Handbook of Emergency Psychiatric Medicine. Baltimore, Md: Lippincott Williams & Wilkins 1995. ![]() Guze BH, Ferng HK, Szuba MP, Richeimer SH. Arlington, VA: American Psychiatric Press 1999. American Psychiatric Press Textbook of Substance Abuse Treatment. Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity. Drug Enforcement Agency: Khat.įarber NB, Hanslick J, Kirby C, et al. Inappropriate prescription of methylphenidate. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. Dopamine levels of two classes of vesicles are differentially depleted by amphetamine. Neural correlates of affect processing and aggression in methamphetamine dependence. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, et al. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Jayaram-Lindström N, Hammarberg A, Beck O, Franck J. Bupropion for the treatment of methamphetamine dependence. 164 (1):160-2.Įlkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Tiihonen J, Kuoppasalmi K, Föhr J, Tuomola P, Kuikanmäki O, Vorma H, et al. Open pilot trial with desipramine and lithium carbonate. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable?. 7:44.īramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, et al. Negative moods correlate with craving in female methamphetamine users enrolled in compulsory detoxification. ![]() The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration. Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT). Pardo-Lozano R, Farré M, Yubero-Lahoz S, O'Mathúna B, Torrens M, Mustata C, et al. Washington, DC: American Psychiatric Association 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |